About Apyx Medical Corp

Apyx Medical Corp. operates in the surgical & medical instruments & apparatus industry. listed on NASDAQ. headquartered in CLEARWATER, FL.

Investment Context for APYX

Apyx Medical Corp (APYX) is publicly traded on NASDAQ within the Healthcare sector , specifically in the Surgical & Medical Instruments & Apparatus industry. The company is headquartered in CLEARWATER, FL.

Business classification: According to SEC filings, Apyx Medical Corp falls under SIC code 3841 — Surgical & Medical Instruments & Apparatus. This classification helps investors compare the company against peers in similar regulatory and operational environments.

Sector outlook: Companies in the Healthcare sector typically share exposure to similar macroeconomic factors — interest rates, regulatory shifts, and consumer demand patterns specific to this industry vertical. Investors evaluating APYX should benchmark against other Healthcare stocks for comparative analysis.

Industry-specific factors: The Surgical & Medical Instruments & Apparatus industry has specific competitive dynamics — market share concentration, supply chain dependencies, and capital intensity that affect valuation. Compare APYX with peer companies in Surgical & Medical Instruments & Apparatus to assess relative positioning.

Regulatory disclosures: With CIK 0000719135, Apyx Medical Corp files mandatory disclosures with the U.S. Securities and Exchange Commission. These include 10-K annual reports, 10-Q quarterly reports, and 8-K material event filings — accessible via the official SEC EDGAR portal for fundamental research.

This page is for educational and research purposes only and does not constitute investment advice. Always conduct independent due diligence and consult a licensed financial advisor before making investment decisions.

Company Information

Industry (SIC)
Surgical & Medical Instruments & Apparatus (SIC 3841)
Exchange
NASDAQ
State / Country
FL
City
CLEARWATER
CIK
0000719135
Important Disclaimer This information is sourced from SEC filings and public data. It is for educational and informational purposes only and is NOT financial advice. Not a recommendation to buy, sell, or hold any security. Consult a qualified financial advisor before making investment decisions.